Drug Trial Radar · NCT00001030
The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
Last checked: Nov 19, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,100
Actual
Start
Not stated
Primary completion
Not stated
Study completion Jun 1996
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the efficacy and safety of clarithromycin alone versus rifabutin alone versus the two drugs in combination for the prevention or delay of Mycobacterium avium Complex (MAC) bacteremia or disseminated MAC disease. To compare other parameters such as survival, toxicity, and quality of life among the three treatment arms. To obtain information on the incidence and clinical grade of targeted gynecologic conditions. Persons with advanced stages of HIV are considered to be at particular risk for developing disseminated MAC disease. The development of an effective regimen for the prevention of disseminated MAC disease may be of substantial benefit in altering the morbidity and possibly the mortality associated with this disease and its treatment.
Conditions
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
Interventions
ClarithromycinDrug
RifabutinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
42 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Therapeutics CRS
Birmingham, Alabama
UCLA CARE Center CRS
Los Angeles, California
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.
Oakland, California
Ucsf Aids Crs
San Francisco, California
Howard University Hosp., Div. of Infectious Diseases, ACTU
Washington D.C., District of Columbia
Univ. of Miami AIDS CRS
Miami, Florida
Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii
Chicago Children's CRS
Chicago, Illinois
Northwestern University CRS
Chicago, Illinois
Cook County Hosp. CORE Ctr.
Chicago, Illinois
Rush Univ. Med. Ctr. ACTG CRS
Chicago, Illinois
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana
Methodist Hosp. of Indiana
Indianapolis, Indiana
Univ. of Iowa Healthcare, Div. of Infectious Diseases
Iowa City, Iowa
Johns Hopkins Adult AIDS CRS
Baltimore, Maryland
Massachusetts General Hospital ACTG CRS
Boston, Massachusetts
Bmc Actg Crs
Boston, Massachusetts
Beth Israel Deaconess - East Campus A0102 CRS
Boston, Massachusetts
Beth Israel Deaconess Med. Ctr., ACTG CRS
Boston, Massachusetts
Hennepin County Med. Ctr., Div. of Infectious Diseases
Minneapolis, Minnesota
University of Minnesota, ACTU
Minneapolis, Minnesota
St. Louis ConnectCare, Infectious Diseases Clinic
St Louis, Missouri
Washington U CRS
St Louis, Missouri
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.
Omaha, Nebraska
SUNY - Buffalo, Erie County Medical Ctr.
Buffalo, New York
NY Univ. HIV/AIDS CRS
New York, New York
Memorial Sloan-Kettering Cancer Ctr.
New York, New York
Beth Israel Med. Ctr. (Mt. Sinai)
New York, New York
Cornell University A2201
New York, New York
Univ. of Rochester ACTG CRS
Rochester, New York
Bronx-Lebanon Hosp. IMPAACT CRS
The Bronx, New York
Unc Aids Crs
Chapel Hill, North Carolina
Carolinas HealthCare System, Carolinas Med. Ctr.
Charlotte, North Carolina
Regional Center for Infectious Disease, Wendover Medical Center CRS
Greensboro, North Carolina
Univ. of Cincinnati CRS
Cincinnati, Ohio
Case CRS
Cleveland, Ohio
MetroHealth CRS
Cleveland, Ohio
The Ohio State Univ. AIDS CRS
Columbus, Ohio
Hosp. of the Univ. of Pennsylvania CRS
Philadelphia, Pennsylvania
The Children's Hosp. of Philadelphia IMPAACT CRS
Philadelphia, Pennsylvania
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.